(Q33631075)

28 July 2017

1 reference

title

Cortical lesions in multiple sclerosis (English)

1 reference

28 July 2017

0 references

Massimiliano Calabrese

series ordinal

1

1 reference

28 July 2017

Massimo Filippi

series ordinal

2

1 reference

28 July 2017

Paolo Gallo

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

13 July 2010

1 reference

28 July 2017

Nature Reviews Neurology

1 reference

28 July 2017

6

1 reference

28 July 2017

8

1 reference

28 July 2017

438-444

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.93

28 July 2017

0 references

cites work

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

A Wallerian degeneration pattern in patients at risk for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Gray matter involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Inflammatory demyelination and neurodegeneration in early multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Focal thinning of the cerebral cortex in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Cortical lesions in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

The distribution of plaques in the cerebrum in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Grey Matter Pathology in Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Extensive cortical remyelination in patients with chronic multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Extensive hippocampal demyelination in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Kainic acid-mediated excitotoxicity as a model for neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Increased expression and function of glutamate transporters in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Gray matter atrophy in multiple sclerosis: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Magnetic resonance evidence of cortical onset of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

The blood-brain barrier in cortical multiple sclerosis lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Multiple sclerosis and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

The significance of perivascular infiltrations in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR Imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Preserved brain adaptive properties in patients with benign multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Grey matter pathology in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Extensive cortical inflammation is associated with epilepsy in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.93

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20625376

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20625376

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20625376

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2010.93

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference